|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.63 USD | +4.29% |
|
+2.88% | +156.09% |
| 05-28 | Barclays Initiates Sutro Biopharma at Overweight With $56 Price Target | MT |
| 05-15 | Sutro Biopharma Shares Rise After Q1 Loss Narrows | MT |
| Market Cap | 491M 428M 396M 371M 696M 46.33B 700M 4.7B 1.82B 22.8B 1.84B 1.8B 79.18B | P/E 2026 * |
-3.38x | P/E 2027 * | -3.97x |
|---|---|---|---|---|---|
| Enterprise Value | 471M 411M 380M 356M 668M 44.43B 672M 4.51B 1.75B 21.87B 1.77B 1.73B 75.94B | EV / Sales 2026 * |
10.4x | EV / Sales 2027 * | 11x |
| Free-Float |
97.74% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sutro Biopharma, Inc.
| 24-07-17 | Indizes: Klein aber fein | |
| 24-07-16 | Indexen: klein is weer fijn | |
| 24-07-16 | Indici: ciò che è piccolo torna in auge | |
| 24-07-16 | Índices: Lo pequeño vuelve a ser bonito | |
| 24-07-16 | Indices : Ce qui est petit redevient mignon |
| 1 day | +4.29% | ||
| 1 week | +2.88% | ||
| Current month | +1.37% | ||
| 1 month | -3.23% | ||
| 3 months | +43.28% | ||
| 6 months | +196.89% | ||
| Current year | +156.09% |
| 1 week | 27.1 |  | 31.46 |
| 1 month | 23.63 | | 31.46 |
| Current year | 10.15 | | 43.85 |
| 1 year | 6.74 | | 43.85 |
| 3 years | 5.23 | | 61.3 |
| 5 years | 5.23 | | 237 |
| 10 years | 5.23 | | 283 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Chung
CEO | Chief Executive Officer | 55 | 2025-03-12 |
Gregory Chow
DFI | Director of Finance/CFO | 53 | 2025-06-01 |
Devendra Luhar
CTO | Chief Tech/Sci/R&D Officer | - | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Petree
BRD | Director/Board Member | 70 | 2009-07-31 |
Joseph Lobacki
BRD | Director/Board Member | 67 | 2017-01-31 |
Michael Dybbs
BRD | Director/Board Member | 51 | 2018-07-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-04 | Free | Director | 10,000 | 0.0603% | ||
| 06-04 | Free | Director | 10,000 | 0.0603% | ||
| 06-04 | Free | Chairman | 10,000 | 0.0603% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.29% | +2.88% | +269.96% | -45.03% | 491M | |
| +1.44% | -1.25% | +64.25% | +116.08% | 55.19B | |
| +4.60% | +3.02% | +57.38% | +62.27% | 45.75B | |
| -1.44% | +0.39% | -14.68% | -15.42% | 22.98B | |
| -2.69% | -2.10% | -6.70% | +363.03% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -18.36% | 16.26B | |
| +0.58% | +1.08% | +18.85% | -36.52% | 15.42B | |
| -1.01% | -2.30% | +28.59% | +173.07% | 13.05B | |
| +4.95% | +11.70% | +125.78% | +261.94% | 12.45B | |
| +3.07% | +0.14% | +29.05% | - | 12.37B | |
| Average | +1.70% | +3.20% | +60.04% | +95.67% | 21.47B | |
| Weighted average by Cap. | +1.63% | +1.50% | +41.30% | +104.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.06M 39.29M 36.39M 34.07M 63.89M 4.25B 64.28M 432M 167M 2.09B 169M 166M 7.27B | 32.22M 28.09M 26.02M 24.36M 45.68M 3.04B 45.95M 309M 120M 1.5B 121M 118M 5.2B |
| Net income | -138M -120M -111M -104M -195M -12.99B -196M -1.32B -511M -6.39B -517M -506M -22.2B | -151M -132M -122M -115M -215M -14.29B -216M -1.45B -562M -7.04B -569M -556M -24.43B |
| Net Debt | -20.08M -17.51M -16.22M -15.18M -28.47M -1.89B -28.64M -192M -74.56M -933M -75.38M -73.76M -3.24B | -138M -120M -111M -104M -195M -13.01B -197M -1.32B -512M -6.4B -517M -506M -22.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 29.63 $ | +4.29% | 287,934 |
| 26-06-17 | 28.41 $ | +0.85% | 499,888 |
| 26-06-16 | 28.17 $ | -6.72% | 344,087 |
| 26-06-15 | 30.20 $ | +4.86% | 188,658 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- STRO Stock
Select your edition
All financial news and data tailored to specific country editions
